BPH. Hyperplasia of prostate
Conditions
Interventions
Intervention 1: Experiment group received 3 milligram melatonin in addition to traditional treatment. After a month, both groups were reanalyzed for IPSS criteria and the improvement of symptoms was e
Treatment - Drugs
Placebo
Experiment group received 3 milligram melatonin in addition to traditional treatment. After a month, both groups were reanalyzed for IPSS criteria and the improvement of symptoms was evaluated.
The traditional treatment and 3 milligrams of placebo were prescribed for the control group. After a month, both groups were reanalyzed for IPSS criteria and the improvement of symptoms was evaluated.
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
50 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion: male patients over 50 without urethral stricture; bladder cancer; prostate cancer; satisfaction; patients with urinary problems and IPSS =8. Exclusion: patients with suspicious for malignancy; male patients over 90; patients with drug interactions with melatonin.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IPSS criteria. Timepoint: Beginning to the study and a month after the study. Method of measurement: By doctor. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed